You are here: All Products  > Abbisko Sells China Rights for CSF-1R Inhibitor to Germany’s Merck in a $605 Million Agreement

Abbisko Sells China Rights for CSF-1R Inhibitor to Germany’s Merck in a $605 Million Agreement

Price: $5.00
Available

Get instant access to this article for unlimited viewing and/or downloading for seven days.


Back to products